Bruno Paiva
Navarre Institute of Health Research(ES)Algarve Biomedical Center(PT)Clinica Universidad de Navarra(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)Universidad de Navarra(ES)Chartered Institute of Management Accountants(GB)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, CAR-T cell therapy research, Chemokine receptors and signaling, Acute Myeloid Leukemia Research
Most-Cited Works
- → International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma(2014)4,760 cited
- → International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma(2016)2,897 cited
- → Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma(2017)635 cited
- → Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma(2013)568 cited
- → Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation(2008)474 cited
- → Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial